Navigation Links
Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research

Bcl-2 Antagonist shown to be therapeutically effective in a mouse model of Chronic Lymphocytic Leukaemia

COPENHAGEN, 18 April 2007 - Santaris Pharma, the Danish biopharmaceutical company developing RNAi drugs, yesterday presented encouraging data at the American Association for Cancer Research Annual Meeting in Los Angeles, showing that SPC2996, the Company's RNA Antagonist of Bcl-2, is therapeutically active in a preclinical model of human Chronic Lymphocytic Leukaemia (CLL).

In collaboration with scientists at the University of Duisberg-Essen in Germany, Santaris researchers reported that white blood cells obtained from CLL patient peripheral blood can be transplanted into immunodeficient mice and reliable engraftment of human CLL cells achieved in the spleen, resulting in focal aggregates of B-lymphocytes carrying surface markers characteristic of CLL cancer cells.

SPC2996 was tested for anti-leukaemic activity over two weeks in this model starting two weeks after transplantation and compared for efficacy with multiple doses of fludarabine, a standard chemotherapy for CLL, as well as a negative control oligonucleotide drug similar to but of different sequence from SPC2996. Therapy with SPC2996 resulted in a 54% reduction (p=0.043) in the number of CLL cells which could be recovered from the spleens of the treated transplanted animals compared to animals not receiving therapy. Fludarabine was also effective in the model whereas the negative control drug was not.

This is the first time that primary CLL cells taken from patient blood have been successfully transplanted and shown long term splenic engraftment in an animal model. The model appears to be validated by the efficacy of the fludarabine in clearing engrafted human CLL cells. The demonstration that single agent therapy with SPC2996, a non-chemotoxic agent inhibiting Bcl-2 expression, also clears CLL cells from splenic engraft
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:7/7/2015)... , July 7, 2015 Noting the need ... pricing policies currently practiced by the rapidly consolidating pharmacy ... (SCPC) today praised Ohio Governor ... a new state effort to help pull back the ... "We applaud Governor Kasich for bringing badly-needed ...
(Date:7/7/2015)... , July 7, 2015 Biobanks ... Helping Your Influence  ,Are you interested ... so, now gain technological and commercial predictions from 2015. ... explore trends in research and development, results, opportunities and ... visiongain shows you what,s possible for biobanking and ...
(Date:7/7/2015)... , 7. Juli 2015 ... -Technik für klinische Studien, gab heute bekannt, dass ... führendes Unternehmen bei Gewinnung und Erhalt von Patienten ... Tochtergesellschaften MediciGlobal , Ltd. und Access to ... auch einen Dienst zum Auffinden von Patienten, die ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4
... Held at 9:00 a.m. Eastern Time Today, May 26, ... (Nasdaq: UTHR ) announced today that the ... ADCIRCA(TM) (tadalafil) tablets for oral administration, with a recommended ... type 5 (PDE5) inhibitor for the treatment of pulmonary ...
... 23 Amid all the speculation over what course ... Replikins Ltd. ( www.replikins.com ) last week ... and determined that the infectivity of the H1N1 virus ... low for the immediate future.The company,s quantitative analysis of ...
Cached Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 2
(Date:7/7/2015)... ... July 08, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. She ... nation’s leading networking organization exclusively for professional women, boasting more than 700,000 members ...
(Date:7/7/2015)... ... , ... Ticket Down is a reputable source of authentic tickets for the CONCACAF Gold ... the Gillette Stadium in Foxborough, Massachusetts. , The second round of matches being held from ... Foxborough, MA. The matches will be held on Friday, July 10th and will feature Honduras ...
(Date:7/7/2015)... ... ... Today, the physicians at Allied Anesthesia, who provide services to Children’s Hospital of ... a series of tips to help children stay safe over the summer months. , ... unsupervised time outdoors. , The most common causes of injuries and death for ...
(Date:7/7/2015)... ... July 07, 2015 , ... Owners of Green Ladies Cleaning ... in the home service category. This honor can only be gained by votes from ... the safety of the products and methods they use daily. Having a home cleaned ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week Northeast Nebraska Imaging, ... website. The website’s goal is to provide patients with detailed information about the ... requesting appointments online. , Part of the center’s rebranding efforts, the website was ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Jessica Goldstein, Vice President / Account Director at Discovery USA, Into its VIP Woman of the Year Circle 2Health News:CONCACAF Group A Tickets: USA vs. Haiti & Honduras vs. Panama at Gillette Stadium: Ticket Down Slashes CONCACAF Gold Cup Group A Tickets in Foxborough 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2
... , TUESDAY, Jan. 24 (HealthDay News) -- Only about ... a flu shot during the H1N1 swine flu epidemic of ... concerned about the disease and nearly 60 percent claimed to ... finding of a University of Michigan report detailing how this ...
... become evermore competitive for scarce funding, scientific journals are ... of others. Still, it may take years to identify ... the actual researchers. "We need a better ... Bioinformatics Institute at Virginia Tech. Garner discussed the problem ...
... A newly published paper from Rhode Island Hospital ... disorders are removed from the upcoming revision to the ... their study, the researchers believe these changes could result ... in the Journal of Clinical Psychiatry and ...
... January 24, 2012 Changes in the endocannabinoid system ... This brain system is responsible for making substances that ... cannabis products, e.g., marijuana. The endocannabinoid system ... research because exposure to cannabis products during adolescence and ...
... are obese, you are at great risk of developing ... Eastern Virginia Medical School could drastically improve your odds ... a major, five-year research grant from the National Institutes ... the development of these diseases linked to obesity. The ...
... 24 (HealthDay News) -- Baltimore is the top U.S. ... that examined patient death and complication rates at nearly ... hospitals performing in the top 5 percent for 26 ... according to those with the highest percentage of top-ranked ...
Cached Medicine News:Health News:How Did Generation X Respond to the H1N1 'Swine' Flu Epidemic? 2Health News:Scientific plagiarism: A growing problem in an era of shrinking research funding 2Health News:The impact of deleting 5 personality disorders in the new DSM-5 2Health News:GABA deficits disturb endocannabinoid system 2Health News:NIH grant targets inflammation in link between obesity and disease 2Health News:NIH grant targets inflammation in link between obesity and disease 3Health News:Baltimore Deemed U.S. City With Most Top-Ranked Hospitals 2
... The Mayo Clinic Elbow Brace, featuring an ... exceptional stability and comfort while allowing for ... of the elbow. The sturdy metal uprights ... securely hold the brace in position, ensure ...
... Elbow Orthosis applies dynamic low-loaded force ... Controls elbow contracture in patients with ... Also good for elbow flexion and ... to apply tension (but not torque) ...
... Aircast aircell technology enables the Pneumatic Armband ... a single pre-inflated aircell, the Armband concentrates ... around the arm, for more support and ... the Armband is designed to conform to ...
... Brace is designed to add the therapeutic ... (sold separately). When inserted into the PneumaticWalker ... surrounds the foot and ankle with soothing ... and pain.,All Cryo/Cuffs can be ordered as ...
Medicine Products: